Filters
By reducing hepatic enzyme levels and improving markers of hepatic steatosis or fibrosis, bariatric surgery may help reduce the risk of non-alcoholic fatty liver disease (NAFLD), according to a study from Portugal presented at ENDO 2020.
The combination of atezolizumab and bevacizumab (atezo-bev) delivered better overall survival (OS) and progression-free survival (PFS) outcomes than sorafenib in patients with untreated, locally advanced metastatic or unresectable hepatocellular carcinoma (HCC), the phase III IMbrave150 trial has shown.
Women are less likely to develop nonalcoholic fatty liver disease (NAFLD), although they are at higher risk of progression to advanced fibrosis once NAFLD is established as compared with men, a study reports.
Obesity appears to be a strong risk factor for liver-related mortality, while exercise exerts a protective effect, a recent study has found.
Cirrhotic survivors of acute kidney injury (AKI) are likely to develop chronic kidney disease, which, in turn, worsens outcomes, a recent study has found.
Liver cirrhosis patients with afebrile bacteraemia remain at risk of worse clinical outcomes and survival, a recent study has shown.
The coronavirus disease 2019 (COVID-19) pandemic is catalyzing the adoption of telemedicine in healthcare. MIMS Doctor examines the practical and medicolegal issues in this evolving field, and explores how barriers can be overcome to facilitate wider use of telemedicine for continuity and enhanced efficiency of care during the COVID-19 crisis and beyond.
Microencapsulated human hepatocytes in alginate may provide a safe and effective alternative to liver transplantation (LT) in infants with acute liver failure (ALF), a new study has shown.
Individuals who develop cancer may have an elevated risk of certain infections in the years leading up to their diagnosis, a retrospective case-control study from Japan showed.
Liver injuries appear to be more common in severe cases of coronavirus disease 2019 (COVID-19), a new meta-analysis reports.
